Sequential infection experiments for quantifying innate and adaptive immunity during influenza infection

Laboratory models are often used to understand the interaction of related pathogens via host immunity. For example, recent experiments where ferrets were exposed to two influenza strains within a short period of time have shown how the effects of cross-immunity vary with the time between exposures and the specific strains used. On the other hand, studies of the workings of different arms of the immune response, and their relative importance, typically use experiments involving a single infection. However, inferring the relative importance of different immune components from this type of data is challenging. Using simulations and mathematical modelling, here we investigate whether the sequential infection experiment design can be used not only to determine immune components contributing to cross-protection, but also to gain insight into the immune response during a single infection. We show that virological data from sequential infection experiments can be used to accurately extract the timing and extent of cross-protection. Moreover, the broad immune components responsible for such cross-protection can be determined. Such data can also be used to infer the timing and strength of some immune components in controlling a primary infection, even in the absence of serological data. By contrast, single infection data cannot be used to reliably recover this information. Hence, sequential infection data enhances our understanding of the mechanisms underlying the control and resolution of infection, and generates new insight into how previous exposure influences the time course of a subsequent infection.

[1]  I. Wilson,et al.  Broadly neutralizing antibodies against influenza virus and prospects for universal therapies. , 2012, Current opinion in virology.

[2]  Ursula Klingmüller,et al.  Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood , 2009, Bioinform..

[3]  J. McVernon,et al.  Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice. , 2012, Molecular pharmaceutics.

[4]  Michael W Deem,et al.  Parallel tempering: theory, applications, and new perspectives. , 2005, Physical chemistry chemical physics : PCCP.

[5]  R. C. Layton,et al.  Higher Level of Replication Efficiency of 2009 (H1N1) Pandemic Influenza Virus than Those of Seasonal and Avian Strains: Kinetics from Epithelial Cell Culture and Computational Modeling , 2010, Journal of Virology.

[6]  A. Hindmarsh,et al.  CVODE, a stiff/nonstiff ODE solver in C , 1996 .

[7]  K. Yap,et al.  Cytotoxic T Cells in the Lungs of Mice Infected with an Influenza A Virus , 1978, Scandinavian journal of immunology.

[8]  J. D. de Pablo,et al.  Optimal allocation of replicas in parallel tempering simulations. , 2005, The Journal of chemical physics.

[9]  J. McVernon,et al.  On the Role of CD8+ T Cells in Determining Recovery Time from Influenza Virus Infection , 2016, Front. Immunol..

[10]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[11]  Louise A. Carolan,et al.  Investigating Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret Model of Infection , 2018, The Journal of infectious diseases.

[12]  D. Kofke,et al.  Selection of temperature intervals for parallel-tempering simulations. , 2005, The Journal of chemical physics.

[13]  A. Perelson,et al.  Simulation and Prediction of the Adaptive Immune Response to Influenza A Virus Infection , 2009, Journal of Virology.

[14]  Alan S. Perelson,et al.  Modeling Within-Host Dynamics of Influenza Virus Infection Including Immune Responses , 2012, PLoS Comput. Biol..

[15]  A. Rollett,et al.  The Monte Carlo Method , 2004 .

[16]  J. Bloom,et al.  Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses , 2014, PLoS pathogens.

[17]  Alan S. Perelson,et al.  Quantifying the Early Immune Response and Adaptive Immune Response Kinetics in Mice Infected with Influenza A Virus , 2010, Journal of Virology.

[18]  A. Perelson,et al.  Influenza A virus infection kinetics: quantitative data and models , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[19]  Ann Cullinane,et al.  Dynamics of Influenza Virus Infection and Pathology , 2010, Journal of Virology.

[20]  A. Perelson,et al.  Kinetics of Influenza A Virus Infection in Humans , 2006, Journal of Virology.

[21]  James M. McCaw,et al.  Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model , 2015, The Journal of infectious diseases.

[22]  Louise A. Carolan,et al.  Characterization of the Localized Immune Response in the Respiratory Tract of Ferrets following Infection with Influenza A and B Viruses , 2015, Journal of Virology.

[23]  M. Plummer,et al.  CODA: convergence diagnosis and output analysis for MCMC , 2006 .

[24]  D. Nayak,et al.  Defective-interfering (DI) RNAs of influenza viruses: origin, structure, expression, and interference. , 1985, Current topics in microbiology and immunology.

[25]  C. Beauchemin,et al.  Progress and trends in mathematical modelling of influenza A virus infections , 2018, Current Opinion in Systems Biology.

[26]  Stephen P. Schoenberger,et al.  Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation , 2001, Nature Immunology.

[27]  Pengxing Cao,et al.  On the extinction probability in models of within-host infection: the role of latency and immunity , 2016, Journal of mathematical biology.

[28]  R. Webster,et al.  Lethal H5N1 influenza viruses escape host anti-viral cytokine responses , 2002, Nature Medicine.

[29]  Donald Geman,et al.  Stochastic Relaxation, Gibbs Distributions, and the Bayesian Restoration of Images , 1984, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[30]  A. Handel,et al.  Mathematical analysis of a mouse experiment suggests little role for resource depletion in controlling influenza infection within host , 2017, 1705.02565.

[31]  R. Ramphal,et al.  Passive serum antibody causes temporary recovery from influenza virus infection of the nose, trachea and lung of nude mice. , 1988, Immunology.

[32]  L M Wahl,et al.  Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection , 1997, Journal of virology.

[33]  J. McVernon,et al.  Quantifying relative within-host replication fitness in influenza virus competition experiments. , 2015, Journal of theoretical biology.

[34]  Evan C. Haskell,et al.  The logistic growth model as an approximating model for viral load measurements of influenza A virus , 2017, Math. Comput. Simul..

[35]  A. Handel,et al.  Mathematical Model Reveals the Role of Memory CD8 T Cell Populations in Recall Responses to Influenza , 2016, Front. Immunol..

[36]  N. Metropolis,et al.  Equation of State Calculations by Fast Computing Machines , 1953, Resonance.

[37]  James M McCaw,et al.  Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages , 2018, The Journal of infectious diseases.

[38]  K. Toellner,et al.  Intrinsic Constraint on Plasmablast Growth and Extrinsic Limits of Plasma Cell Survival , 2000, The Journal of experimental medicine.

[39]  Udo Reichl,et al.  Mathematical model of influenza A virus production in large-scale microcarrier culture. , 2005, Biotechnology and bioengineering.

[40]  Mats O. Karlsson,et al.  Likelihood based approaches to handling data below the quantification limit using NONMEM VI , 2008, Journal of Pharmacokinetics and Pharmacodynamics.

[41]  Ruy M Ribeiro,et al.  Modeling amantadine treatment of influenza A virus in vitro. , 2008, Journal of theoretical biology.

[42]  C. Geyer Markov Chain Monte Carlo Maximum Likelihood , 1991 .

[43]  James M. McCaw,et al.  Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies , 2015, PLoS Comput. Biol..

[44]  Hana M. Dobrovolny,et al.  Assessing Mathematical Models of Influenza Infections Using Features of the Immune Response , 2013, PloS one.

[45]  Gilles Clermont,et al.  A Dynamical Model of Human Immune Response to Influenza a Virus Infection , 2006 .

[46]  Andreas Handel,et al.  Towards a quantitative understanding of the within-host dynamics of influenza A infections , 2010, Journal of The Royal Society Interface.

[47]  N. Dimmock,et al.  Defective interfering viruses and their potential as antiviral agents , 2010, Reviews in medical virology.

[48]  D. Rubin,et al.  Inference from Iterative Simulation Using Multiple Sequences , 1992 .

[49]  C. Beauchemin,et al.  Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility , 2015, PloS one.

[50]  L. Wahl,et al.  Perspectives on the basic reproductive ratio , 2005, Journal of The Royal Society Interface.

[51]  G. Bocharov,et al.  Mathematical model of antiviral immune response. III. Influenza A virus infection. , 1994, Journal of theoretical biology.

[52]  T. Kishida,et al.  Effect of anti-interferon serum of influenza virus infection in mice. , 1983, Antiviral research.

[53]  James M. McCaw,et al.  Reducing Uncertainty in Within-Host Parameter Estimates of Influenza Infection by Measuring Both Infectious and Total Viral Load , 2013, PloS one.

[54]  Guy Boivin,et al.  The H275Y Neuraminidase Mutation of the Pandemic A/H1N1 Influenza Virus Lengthens the Eclipse Phase and Reduces Viral Output of Infected Cells, Potentially Compromising Fitness in Ferrets , 2012, Journal of Virology.

[55]  Andreas Handel,et al.  Neuraminidase Inhibitor Resistance in Influenza: Assessing the Danger of Its Generation and Spread , 2007, PLoS Comput. Biol..

[56]  Peter A. J. Hilbers,et al.  A Bayesian approach to targeted experiment design , 2012, Bioinform..

[57]  G. Marchuk,et al.  Mathematical model of antiviral immune response. I. Data analysis, generalized picture construction and parameters evaluation for hepatitis B. , 1991, Journal of theoretical biology.

[58]  J. McVernon,et al.  Intranasal Administration of the TLR 2 Agonist Pam 2 Cys Provides Rapid Protection against In fl uenza in Mice , 2012 .

[59]  Kylie M. Quinn,et al.  Modelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host. , 2016, Journal of theoretical biology.

[60]  Andreas Handel,et al.  Modeling inoculum dose dependent patterns of acute virus infections. , 2014, Journal of theoretical biology.

[61]  T. Iwasaki,et al.  Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production. , 1977, Journal of immunology.